Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -8.57 | 50.14 |
| PEG Ratio (TTM) | 0.44 | 4.29 |
| P/S Ratio (TTM) | 1.54 | 3.39 |
| P/B Ratio (TTM) | 1.31 | 7.42 |
| P/FCF Ratio (TTM) | -13.33 | 43.25 |
| Price to 5YR AVG Earnings Ratio | N/A | 91.74 |
| Price to 5YR AVG FCF Ratio | N/A | 158.95 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -10.60% | 8.69% |
| ROE (TTM) | -13.55% | 17.38% |
| Net Profit Margin (TTM) | -18.94% | 8.45% |
| ROIC 5YR AVG | N/A | 18.45% |
Growth (12%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -17.83% | -14.50% | N/A |
| Revenue | 0.70% | 4.79% | N/A |
| Net Income | -15.93% | -13.92% | N/A |
| Cash Flow | 18.03% | -160.24% | N/A |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 4.23 | 1.23 |
| Quick Ratio (TTM) | 4.23 | 0.97 |
| D/E Ratio (TTM) | N/A | 0.33 |
| Interest Coverage (TTM) | -2,185.64 | 21.07 |
| Piotroski F-Score | 3 | 7 |
| Altman Z-Score | N/A | 5.37 |
| LTL to 5YR AVG FCF | N/A | 9.48 |
| Shares Outstanding Growth 5YR AVG | N/A | 40.90% |